Sleep Disorders

Treating restless leg syndrome: the present and the future 10:05
Treating restless leg syndrome: the present and the future
Diego Garcia-Borreguero • 30 Sep 2021
Daridorexant: a breakthrough for insomnia treatment in Europe? 5:10
Daridorexant: a breakthrough for insomnia treatment in Europe?
Diego Garcia-Borreguero • 30 Sep 2021
Dual orexin receptor antagonists – the story so far and daridorexant Phase III data 17:01
Dual orexin receptor antagonists – the story so far and daridorexant Phase III data
Diego Garcia-Borreguero • 30 Sep 2021
Predicting progression of iRBD to neurodegenerative disease 2:20
Predicting progression of iRBD to neurodegenerative disease
Claudio Bassetti • 23 Sep 2021
RBD and Parkinson’s disease: news from MDS 2021 2:14
RBD and Parkinson’s disease: news from MDS 2021
Claudio Bassetti • 23 Sep 2021
Diagnosing RBD in the context of neurodegeneration 2:46
Diagnosing RBD in the context of neurodegeneration
Claudio Bassetti • 23 Sep 2021
Why do presenting symptoms differ in PD? 2:33
Why do presenting symptoms differ in PD?
Claudio Bassetti • 23 Sep 2021
Sleep as a link between the brain and the gut 2:09
Sleep as a link between the brain and the gut
Liborio Parrino • 27 Sep 2021
Insomnia management: where are current strategies falling short? 4:02
Insomnia management: where are current strategies falling short?
Liborio Parrino • 27 Sep 2021
Orexin receptor antagonists for the treatment of insomnia 3:30
Orexin receptor antagonists for the treatment of insomnia
Liborio Parrino • 27 Sep 2021
The global burden of insomnia 6:09
The global burden of insomnia
Liborio Parrino • 27 Sep 2021
Update on the evaluation and management of narcolepsy 7:41
Update on the evaluation and management of narcolepsy
Claudio Bassetti • 23 Sep 2021
SPHYNCS: an observational study for the discovery of markers of the narcoleptic borderland disorders 4:57
SPHYNCS: an observational study for the discovery of markers of the narcoleptic borderland disorders
Claudio Bassetti • 23 Sep 2021
Using video analysis to evaluate nelotanserin as symptomatic treatment for RBD in dementia 2:56
Using video analysis to evaluate nelotanserin as symptomatic treatment for RBD in dementia
Ambra Stefani • 23 Jun 2021
Sleep disorders and neurodegeneration: which comes first? 2:08
Sleep disorders and neurodegeneration: which comes first?
Ambra Stefani • 23 Jun 2021
Alpha-synuclein aggregation in the olfactory mucosa of patients with isolated RBD vs. PD 2:54
Alpha-synuclein aggregation in the olfactory mucosa of patients with isolated RBD vs. PD
Ambra Stefani • 23 Jun 2021
The content of VJNeurology is intended for healthcare professionals